Annual CFO
-$38.97 M
-$43.02 M-1063.94%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual cash flow from operations is -$38.97 million, with the most recent change of -$43.02 million (-1063.94%) on December 31, 2023.
- During the last 3 years, LVTX annual CFO has fallen by -$29.66 million (-318.74%).
- LVTX annual CFO is now -1063.94% below its all-time high of $4.04 million, reached on December 31, 2022.
Performance
LVTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.63 M
-$246.00 K-2.93%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly cash flow from operations is -$8.63 million, with the most recent change of -$246.00 thousand (-2.93%) on September 30, 2024.
- Over the past year, LVTX quarterly CFO has dropped by -$1.52 million (-21.43%).
- LVTX quarterly CFO is now -124.15% below its all-time high of $35.73 million, reached on December 31, 2022.
Performance
LVTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$28.60 M
-$1.52 M-5.62%
September 30, 2024
Summary
- As of February 8, 2025, LVTX TTM cash flow from operations is -$28.60 million, with the most recent change of -$1.52 million (-5.62%) on September 30, 2024.
- Over the past year, LVTX TTM CFO has dropped by -$35.83 million (-495.74%).
- LVTX TTM CFO is now -495.74% below its all-time high of $7.23 million, reached on September 30, 2023.
Performance
LVTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LVTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1063.9% | -21.4% | -495.7% |
| 3 y3 years | -318.7% | -21.4% | -495.7% |
| 5 y5 years | -352.4% | -21.4% | -495.7% |
LVTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1063.9% | at low | -124.2% | +39.8% | -495.7% | +26.9% |
| 5 y | 5-year | -1063.9% | at low | -124.2% | +39.8% | -495.7% | +26.9% |
| alltime | all time | -1063.9% | at low | -124.2% | +39.8% | -495.7% | +26.9% |
LAVA Therapeutics NV Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.63 M(+2.9%) | -$28.60 M(+5.6%) |
| Jun 2024 | - | -$8.38 M(+645.2%) | -$27.08 M(-14.7%) |
| Mar 2024 | - | -$1.13 M(-89.2%) | -$31.76 M(-18.5%) |
| Dec 2023 | -$38.97 M(-1063.9%) | -$10.46 M(+47.2%) | -$38.97 M(-639.2%) |
| Sep 2023 | - | -$7.11 M(-45.6%) | $7.23 M(<-9900.0%) |
| Jun 2023 | - | -$13.06 M(+56.7%) | -$9000.00(-100.3%) |
| Mar 2023 | - | -$8.34 M(-123.3%) | $3.34 M(-17.5%) |
| Dec 2022 | $4.04 M | $35.73 M(-349.1%) | $4.04 M(-110.3%) |
| Sep 2022 | - | -$14.34 M(+47.6%) | -$39.13 M(+18.7%) |
| Jun 2022 | - | -$9.72 M(+27.4%) | -$32.96 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.63 M(+2.6%) | -$31.78 M(+10.9%) |
| Dec 2021 | -$28.65 M(+207.8%) | -$7.43 M(-9.1%) | -$28.65 M(+1.3%) |
| Sep 2021 | - | -$8.18 M(-4.2%) | -$28.27 M(+18.0%) |
| Jun 2021 | - | -$8.54 M(+89.7%) | -$23.96 M(+111.2%) |
| Mar 2021 | - | -$4.50 M(-36.3%) | -$11.35 M(+21.9%) |
| Dec 2020 | -$9.31 M(+8.0%) | -$7.06 M(+82.6%) | -$9.31 M(+314.2%) |
| Sep 2020 | - | -$3.87 M(-194.8%) | -$2.25 M(-238.7%) |
| Jun 2020 | - | $4.08 M(-265.9%) | $1.62 M(-165.9%) |
| Mar 2020 | - | -$2.46 M | -$2.46 M |
| Dec 2019 | -$8.62 M | - | - |
FAQ
- What is LAVA Therapeutics NV annual cash flow from operations?
- What is the all time high annual CFO for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual CFO year-on-year change?
- What is LAVA Therapeutics NV quarterly cash flow from operations?
- What is the all time high quarterly CFO for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly CFO year-on-year change?
- What is LAVA Therapeutics NV TTM cash flow from operations?
- What is the all time high TTM CFO for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV TTM CFO year-on-year change?
What is LAVA Therapeutics NV annual cash flow from operations?
The current annual CFO of LVTX is -$38.97 M
What is the all time high annual CFO for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual cash flow from operations is $4.04 M
What is LAVA Therapeutics NV annual CFO year-on-year change?
Over the past year, LVTX annual cash flow from operations has changed by -$43.02 M (-1063.94%)
What is LAVA Therapeutics NV quarterly cash flow from operations?
The current quarterly CFO of LVTX is -$8.63 M
What is the all time high quarterly CFO for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly cash flow from operations is $35.73 M
What is LAVA Therapeutics NV quarterly CFO year-on-year change?
Over the past year, LVTX quarterly cash flow from operations has changed by -$1.52 M (-21.43%)
What is LAVA Therapeutics NV TTM cash flow from operations?
The current TTM CFO of LVTX is -$28.60 M
What is the all time high TTM CFO for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high TTM cash flow from operations is $7.23 M
What is LAVA Therapeutics NV TTM CFO year-on-year change?
Over the past year, LVTX TTM cash flow from operations has changed by -$35.83 M (-495.74%)